Whoop, a Boston-based biometrics-monitoring wristband startup, raises $25M Series C led by UAE71 Capital, has raised ~$50M total to date
Whoop took a different approach to try and break into the crowded wearable device market: Start by winning over professional athletes, then gradually expand sales to a wider array of consumers.
Context & Ripple Effects
In 2018, Whoop was still a niche bet: a Boston startup with about [[a:~$50m|$50M raised to date]] after this $25M Series C, betting that winning professional athletes first would let it break into a wearable market crowded with consumer gadget makers. The bet hinged on selling a subscription coaching service alongside a screenless band rather than competing on device features.
The subsequent record validates the structure: follow-on rounds at rising valuations — a $55M Series D in 2019, $100M at a $1.2B valuation in 2020, and SoftBank's $200M at $3.6B in 2021 — culminating in a $575M raise at $10.1B with $1B in ARR reported for 2025. This Series C is the early rung of that ladder.
First-order effects
- UAE71 Capital's lead gives Whoop the runway to push beyond its professional-athlete beachhead into general consumer sales, testing whether the subscription band works outside elite sport.
Second-order effects
- Rivals in the crowded wearable field face a competitor whose economics rest on recurring subscription revenue per active device rather than one-time hardware margins, pressuring them toward services of their own.
Third-order effects
- If the pattern holds, screenless subscription-first wearables become a distinct category from consumer smartwatches — a path that has since carried Whoop to IPO preparation and a planned 75% staff expansion in 2026.
The trend: Consumer wearables are consolidating around subscription-based health platforms backed by successive mega-rounds, with Whoop's athlete-first playbook as an early template.